Hilde Windels is currently CEO of MyCartis and member of the board. She holds a Masters in Economics (Commercial Engineer) from the University of Leuven (Belgium) and has 20 years of experience in biotech. Her track record includes building and structuring organizations, private fundraising, public capital markets, business & corporate strategy and multiple board memberships. She worked as CFO for several biotech companies until 2011 when Hilde joined Biocartis. She started as CFO, transitioning to the co-CEO role as of 2015 till mid-2017. Mrs. Hilde Windels is member of the boards of Biocartis, Erytech, Celyad, MDxHealth and VIB.
MEET HILDE WINDELS @ #KFG2019
Hilde Windels will be part of the EDUCATE session of the programme.